Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Advanced patent-based purification technology ensures high-purity troxerutin. Significant cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN105622696A reveals emulsification leaching for DHEA. Achieves 99% purity with reduced costs and simplified supply chain for pharmaceutical intermediates.
Advanced synthesis of Melphalan and salts via pH-controlled purification. Cost-effective manufacturing using technical grade raw materials for global supply chains.
Novel emulsification leaching patent CN105622696A enables over 99% purity DHEA. Reduced cost and simplified supply chain for pharmaceutical manufacturers globally.
Patent CN1356334A details novel Ru-H4-BINAP complexes for efficient ketone reduction, offering high ee values and scalable routes for chiral alcohol intermediates.
Patent CN1356334A reveals novel Ru-H4-BINAP-diamine catalysts enabling high-ee asymmetric hydrogenation of ketones, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN106164260B enables high-yield biocatalytic synthesis of (R)-6-hydroxy-8-chlorooctanoate. Discover cost-effective supply chain solutions for lipoic acid precursors.
Analysis of patent CN103694230B reveals amino acid co-crystallization for SGLT-2 inhibitors. Ensures supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN108033889A reveals a continuous Pd/Al2O3 catalytic method for 2,4-dimethoxyaniline, offering high purity, safety, and significant supply chain cost advantages.
Patent CN110028422B reveals a reversible Michael addition method for amino protection using imidazole hydrochloride, offering cost-effective and scalable solutions for pharmaceutical intermediate manufacturing.
Patent CN104693213A details high-yield Frutinones synthesis. Offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing partners globally.
Patent CN101823979B details a zero-emission phenacetin process using reactor-coupled simulated moving bed chromatography for high-purity pharmaceutical intermediates.
Novel patent CN103274911B details high-purity DHA synthesis. Offers cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing.
Patent CN100999493A details a streamlined 2-step synthesis for quinolone intermediates, offering significant cost reduction in pharmaceutical manufacturing and enhanced supply chain reliability.
Patent CN114195633A details a novel carbonylation route for Ibuprofen Impurity F, offering high purity without chromatography for cost-effective API manufacturing.
Patent CN119614528B reveals enhanced hydroxysteroid dehydrogenase mutants for steroid synthesis, offering improved stability and cost reduction in pharmaceutical manufacturing.
Patent CN118598797A reveals a novel organocatalytic route for chiral fluorinated piperidines, offering safer manufacturing and improved supply chain reliability for pharmaceutical intermediates.
Novel synthesis of Amiodarone Impurity G ensures high purity reference standards for quality control and supply chain stability in pharmaceutical manufacturing.
Patent CN116536279B reveals novel biocatalytic route for DHEA. Achieves high yield and purity with reduced environmental impact for pharmaceutical supply chains.
Novel synthetic method for high-purity amino sugar intermediates ensuring cost reduction and supply chain reliability for pharmaceutical manufacturing.